Recent mechanistic studies show that CIRBP displayed the ability to bypass replicative senescence through activation of the ERK1/2 signaling pathway in primary mouse embryonic fibroblasts7, further evidence for CIRBP’s oncogenic function is that CIRBP promotes the development of liver cancer by increasing ROS accumulation and CD133 expression10. The gene discussed is CIRBP; the disease is liver cancer.